EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody

Reda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, Haijuan Du, Jason Gorman, Madhu Prabhakaran, Jordan E Becker, Tatsiana Bylund, Sam Charaf, Xuejun Chen, Myungjin Lee, Darcy R Harris und 10 weitere

Structure · 2025

DOI: 10.1016/j.str.2025.07.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2025. Verfasst von Reda Rawi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic ad…. Hauptthemen laut MEDLINE: Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, NIGMS NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The N terminus of the H3 subtype of influenza virus hemagglutinin is ∼10 residues longer than the N termini of most other hemagglutinins. As conserved, exposed, and linear regions may be good vaccine targets, we investigated the vaccine utility of the extended H3-N terminus. First, we identified antibody 5E10, for which structure and binding analyses revealed recognition of the H3-N terminus. Second, we immunized mice with immunogens incorporating the H3-N terminus, boosted with hemagglutinin trimer, and isolated antibodies from immunogen-elicited B cells that bound both H3-N terminus and hemagglutinin trimer. However, hemagglutinin-complex structures of two such antibodies, 3864-6 and 3864-10, that neutralized H3-influenza strains, revealed only peripheral recognition of the hemagglutinin N terminus. Collectively, these results reveal the N terminus of H3 hemagglutinin to be a suboptimal vaccine target and suggest that-in addition to being conserved, flexible, and accessible-other factors influence the elicitation of potent broadly neutralizing responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, NeutralizingAntibodies, ViralAnimalsMiceInfluenza VaccinesHumansModels, MolecularFemaleMice, Inbred BALB CProtein BindingEpitopes

Stichwörter der Autor:innen

cryo-EMimmune focusinginfluenza H3 N terminuspeptide immunizationprime-booststructure-based vaccine design

Substanzen

Hemagglutinin Glycoproteins, Influenza VirusAntibodies, NeutralizingAntibodies, ViralInfluenza VaccinesEpitopes

Autor:innen und Institutionen

  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: reda.rawi@nih.gov.
  • Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032,…
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and…
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicia…

Förderung

  • Gates Foundation
  • NIGMS NIH HHS
  • Intramural NIH HHS
  • National Institute of Allergy and Infectious Diseases Vaccine Research Center
  • Bill and Melinda Gates Foundation
  • New York State Foundation for Science, Technology and Innovation
  • National Institutes of Health
  • Foundation for the National Institutes of Health

Zitieren

APA

Rawi, R., Morano, N. C., Cheung, C. S., Du, H., Gorman, J., Prabhakaran, M., Becker, J. E., Bylund, T., Charaf, S., Chen, X., Lee, M., Harris, D. R., Olia, A. S., Ou, L., Wang, L., Wang, S., Zhang, B., Kanekiyo, M., McDermott, A. B., …, & Kwong, P. D. (2025). The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody. Structure. https://doi.org/10.1016/j.str.2025.07.015

Vancouver

Rawi R, Morano NC, Cheung CS, Du H, Gorman J, Prabhakaran M, et al. The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody. Structure. 2025. doi:10.1016/j.str.2025.07.015

BibTeX
@article{Rawi2025,
  author = {Rawi, Reda and Morano, Nicholas C and Cheung, Crystal Sao-Fong and Du, Haijuan and Gorman, Jason and Prabhakaran, Madhu and Becker, Jordan E and Bylund, Tatsiana and Charaf, Sam and Chen, Xuejun and Lee, Myungjin and Harris, Darcy R and Olia, Adam S and Ou, Li and Wang, Lingshu and Wang, Shuishu and Zhang, Baoshan and Kanekiyo, Masaru and McDermott, Adrian B and Zhou, Tongqing and Shapiro, Lawrence and Kwong, Peter D},
  title = {The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody},
  journal = {Structure},
  year = {2025},
  doi = {10.1016/j.str.2025.07.015}
}
Kostenlos starten →